Skip to main content
. 2017 Aug 31;13(3):239–247. doi: 10.1016/j.ajps.2017.08.008

Fig. 5.

Fig. 5

In vitro drug release profile of CPM loaded GRS-PVA nanofibers (blue) in comparison to the commercial CPM tablets (red).

HHS Vulnerability Disclosure